Table of Content



1 Relevant Concepts of Octreotide
1.1 Indications for Octreotide
1.2 Development of Octreotide in China
1.3 Governmental Approval of Octreotide in China
1.4 The Impact of COVID-19 on Octreotide Sales in China


2 Sales of Octreotide in China, 2016-2020
2.1 Sales Value of Octreotide
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Octreotide
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Octreotide by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Analysis of Other Dosage Form


3 Analysis of Major Octreotide Manufacturers in China in 2020
3.1 Analysis of Market Share of Major Octreotide Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Novartis Pharma Schweiz AG
3.2.1 Enterprise Profile
3.2.2 Sales of SANDOSTATIN (Novartis Pharma Schweiz AG’s Octreotide) in China
3.3 Sandoz GmbH/Abbott Biologicals B.V.
3.3.1 Enterprise Profile
3.3.2 Sales of SANDOSTATIN LAR (Sandoz GmbH/Abbott Biologicals B.V.’s Octreotide) in China
3.4 Sinopharm Yixin Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Lierning (Sinopharm Yixin Pharmaceutical Co., Ltd.’s Octreotide) in China
3.5 Shanghai No. 1 Biochemical & Pharmaceutical Co. Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Shengaoding (Shanghai No. 1 Biochemical & Pharmaceutical Co. Ltd.’s Octreotide) in China
3.6 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Anli (Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd.’s Octreotide) in China


4 Prices of Octreotide for Different Manufacturers in China, 2020-2021
4.1 Novartis Pharma Schweiz AG (SANDOSTATIN)
4.2 Sandoz GmbH/Abbott Biologicals B.V. (SANDOSTATIN LAR)
4.3 Sinopharm Yixin Pharmaceutical Co., Ltd. (Lierning)
4.4 Shanghai No. 1 Biochemical & Pharmaceutical Co. Ltd. (Shengaoding)
4.5 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd. (Anli)


5 Prospect of Chinese Octreotide Market, 2021-2025
5.1 Influential Factors of Chinese Octreotide Market Development
5.1.1 The Impact of COVID-19 on Chinese Octreotide Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Octreotide Injection Registration in China
Chart Sales Value of Octreotide Injection over the World
Chart Sales Value of Octreotide Injection in China, 2016-2020
Chart Sales Value of Octreotide Injection in China by Region, 2016-2020
Chart Sales Volume of Octreotide Injection in China, 2016-2020
Chart Sales Volume of Octreotide Injection in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Octreotide Injection Manufacturers in China, 2016-2020
Chart Sales Value and Volume of SANDOSTATIN in China, 2016-2020
Chart Sales Value and Volume of SANDOSTATIN LAR in China, 2016-2020
Chart Sales Value and Volume of Lierning in China, 2016-2020
Chart Sales Value and Volume of Shengaoding in China, 2016-2020
Chart Sales Value and Volume of Anli in China, 2016-2020
Chart Referential Prices of SANDOSTATIN in China by Region, 2020-2021
Chart Referential Prices of SANDOSTATIN LAR in China by Region, 2020-2021
Chart Referential Prices of Lierning in China by Region, 2020-2021
Chart Referential Prices of Shengaoding in China by Region, 2020-2021
Chart Referential Prices of Anli in China by Region, 2020-2021
Chart Forecast on Sales Value of Octreotide Injection in China, 2021-2025
Chart Forecast on Sales Volume of Octreotide Injection in China, 2021-2025



List of Tables

Table of Contents


1 Relevant Concepts of Octreotide



  • 1.1 Indications for Octreotide

  • 1.2 Development of Octreotide in China     

  • 1.3 Governmental Approval of Octreotide in China

  • 1.4 The Impact of COVID-19 on Octreotide Sales in China


 


2 Sales of Octreotide in China, 2016-2020  



  • 2.1 Sales Value of Octreotide

  • 2.1.1 Overall Sales Value

  • 2.1.2 Sales Value by Region 

  • 2.2 Sales Volume of Octreotide    

  • 2.2.1 Overall Sales Volume  

  • 2.2.2 Sales Volume by Region     

  • 2.3 Sales of Octreotide by Dosage Form in China, 2016-2020   

  • 2.3.1 Injection

  • 2.3.2 Analysis of Other Dosage Form


 


3 Analysis of Major Octreotide Manufacturers in China in 2020



  • 3.1 Analysis of Market Share of Major Octreotide Manufacturers     

  • 3.1.1 Investigation on Market Share by Sales Value    

  • 3.1.2 Investigation on Market Share by Sales volume 

  • 3.2 Novartis Pharma Schweiz AG       

  • 3.2.1 Enterprise Profile 

  • 3.2.2 Sales of SANDOSTATIN (Novartis Pharma Schweiz AG’s Octreotide) in China

  • 3.3  Sandoz GmbH/Abbott Biologicals B.V.

  • 3.3.1 Enterprise Profile 

  • 3.3.2 Sales of SANDOSTATIN LAR (Sandoz GmbH/Abbott Biologicals B.V.’s Octreotide) in China

  • 3.4 Sinopharm Yixin Pharmaceutical Co., Ltd.

  • 3.4.1 Enterprise Profile 

  • 3.4.2 Sales of Lierning (Sinopharm Yixin Pharmaceutical Co., Ltd.’s Octreotide) in China

  • 3.5 Shanghai No. 1 Biochemical & Pharmaceutical Co. Ltd.

  • 3.5.1 Enterprise Profile 

  • 3.5.2 Sales of Shengaoding (Shanghai No. 1 Biochemical & Pharmaceutical Co. Ltd.’s Octreotide) in China

  • 3.6 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd.

  • 3.6.1 Enterprise Profile 

  • 3.6.2 Sales of Anli (Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd.’s Octreotide) in China


 


4 Prices of Octreotide for Different Manufacturers in China, 2020-2021



  • 4.1 Novartis Pharma Schweiz AG (SANDOSTATIN) 

  • 4.2 Sandoz GmbH/Abbott Biologicals B.V. (SANDOSTATIN LAR)

  • 4.3 Sinopharm Yixin Pharmaceutical Co., Ltd. (Lierning)

  • 4.4 Shanghai No. 1 Biochemical & Pharmaceutical Co. Ltd. (Shengaoding)

  • 4.5 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Co., Ltd. (Anli)


 


5 Prospect of Chinese Octreotide Market, 2021-2025



  • 5.1 Influential Factors of Chinese Octreotide Market Development

  • 5.1.1 The Impact of COVID-19 on Chinese Octreotide Market

  • 5.1.2 Market Drivers and Opportunities

  • 5.1.3 Market Threats and Challenges

  • 5.2 Forecast on Market Size 

  • 5.3 Forecast on Market Trend


 


List of Charts



  • Chart Patent Information About Octreotide Injection Registration in China

  • Chart Sales Value of Octreotide Injection over the World

  • Chart Sales Value of Octreotide Injection in China, 2016-2020

  • Chart Sales Value of Octreotide Injection in China by Region, 2016-2020

  • Chart Sales Volume of Octreotide Injection in China, 2016-2020

  • Chart Sales Volume of Octreotide Injection in China by Region, 2016-2020

  • Chart Market Share by Sales Value of Top Octreotide Injection Manufacturers in China, 2016-2020

  • Chart Sales Value and Volume of SANDOSTATIN in China, 2016-2020

  • Chart Sales Value and Volume of SANDOSTATIN LAR in China, 2016-2020

  • Chart Sales Value and Volume of Lierning in China, 2016-2020

  • Chart Sales Value and Volume of Shengaoding in China, 2016-2020

  • Chart Sales Value and Volume of Anli in China, 2016-2020

  • Chart Referential Prices of SANDOSTATIN in China by Region, 2020-2021          

  • Chart Referential Prices of SANDOSTATIN LAR in China by Region, 2020-2021

  • Chart Referential Prices of Lierning in China by Region, 2020-2021  

  • Chart Referential Prices of Shengaoding in China by Region, 2020-2021         

  • Chart Referential Prices of Anli in China by Region, 2020-2021

  • Chart Forecast on Sales Value of Octreotide Injection in China, 2021-2025

  • Chart Forecast on Sales Volume of Octreotide Injection in China, 2021-2025